Key result
Novel endovascular embolization techniques show high technical success and sac shrinkage for Type II endoleaks.
Why the study?
Type II endoleaks are a frequent complication after endovascular aneurysm repair that pose a risk of aneurysm expansion, prompting evaluation of modern management techniques beyond traditional embolization methods.
Do novel endovascular techniques (transcaval embolization, laser-assisted transgraft embolization, and prophylactic shape memory polymer sac embolization) improve technical and clinical success in preventing or treating Type II endoleaks after EVAR compared to conventional embolization methods?
Do novel endovascular techniques (transcaval embolization, laser-assisted transgraft embolization, and prophylactic shape memory polymer sac embolization) improve technical and clinical success in preventing or treating Type II endoleaks after EVAR compared to conventional embolization methods?
Novel techniques including transcaval embolization, transgraft embolization, and prophylactic shape memory polymer sac filling offer promising, high-technical-success alternatives for anatomically complex or refractory Type II endoleaks after EVAR, though larger prospective studies are needed before routine adoption.
Answers are grounded in this paper and cite their sources.
May offer options for refractory Type II endoleaks; leaves open need for randomized trials before adoption.
Background: Type II endoleaks (T2ELs) are a frequent complication after endovascular aneurysm repair (EVAR), posing a risk of aneurysm expansion. This review evaluates modern techniques for T2ELs management, moving beyond traditional embolization methods. Methods: Recent controlled trials and observational studies were analyzed to trace evidence on conventional and novel techniques employed in managing T2ELs. Results: Novel techniques, such as transcaval embolization (TCE) and laser-assisted transgraft embolization (LATE), have demonstrated encouraging early technical and clinical outcomes, although the available evidence remains limited. In addition, shape memory polymer (SMP) embolization resulted in significant sac shrinkage in >85% of patients and prevented clinically significant T2ELs. Conclusions: TCE, LATE, and prophylactic SMP embolization are promising alternatives to conventional methods, offering high technical success and the potential to reduce reinterventions. Larger studies are needed to confirm long-term outcomes and define optimal use.
No takes yet. Share an insight, caveat, or question.
Pietrzak et al. (2026) conducted a review in Type II endoleaks (T2ELs) after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAA). Novel endovascular techniques (transcaval embolization [TCE], laser-assisted transgraft embolization [LATE], long-needle transgraft embolization, and prophylactic shape memory polymer [SMP] sac embolization) vs. Conventional embolization methods (transarterial embolization [TAE] and direct translumbar sac puncture) or conservative imaging surveillance was evaluated on Technical success (successful target access and completion of embolization) and clinical success (absence of clinically relevant aneurysm sac expansion during follow-up with no need for T2EL-related reintervention). Transcaval embolization, laser-assisted transgraft embolization, and prophylactic shape memory polymer embolization (>85% sac shrinkage) show high technical success in managing Type II endoleaks.
Synapse has enriched 10 related papers. Consider them for comparative context: